Partnering with eye care professionals to advance vision†1 for every eye.2,3
We support each practice’s overall business success while helping them bring high quality contact lenses to wearers with an extraordinarily wide range of vision needs.2,3
Nearly 43 million contact lens wearers wear CooperVision® contact lenses worldwide.‡3
CooperVision is #1 for the range of soft contact lens prescription options it offers worldwide.§4
CooperVision® contact lens range can provide correction for 99.96% of all your patients.2,3
Why CooperVision®
Commitment to myopia management
CooperVision is a world leader in myopia management, committed to partnering with eye care professionals to help children with myopia receive evidence-based5-13 treatment for a lifetime of better vision.*צ6,7
Innovative technology
Our commitment to innovation makes it possible for more people to wear contact lenses.
A contact lens for every stage in life
Making contact lenses accessible to more wearers for a wide range of correction needs and budgets, at any stage in life.
Technology driven services and tools
Our commitment to innovation makes it possible for more people to wear contact lenses.
We design with intention & are powered by people
We thoughtfully design our products and packaging to make efficient use of resources while starting to reduce our carbon footprint.**††‡‡1 We collaborate and innovate, embracing our ingenuity to care for our planet and each other.
*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
†Combination of 2022 market research based on global volume data and internal estimates.
‡Based on internal estimates for rolling 12-month sales data, as of October 2024. Includes 1 day disposable, 2 week replacement, monthly replacement disposable contact lenses and specialty lens designs including Ortho-k and sclerals.
§Based on Rx option combinations (sphere, cylinder, axis & add) manufactured, across all soft lenses in sphere, toric & multifocal, in SiHy and hydrogel from 4 main manufacturers. Includes 1 Day, 2 weekly, and monthly disposable contact lenses. Cosmetic & Photochromatic contact lenses not included. Multiple base curve variants not included.
◊MiSight® 1 day, designed for myopia control, shows sustained slowing of eye growth over time on average. While eyes are still growing; children fit ages 8-12 and followed for 6-years. n=40.
¶Compared to a single vision 1-day lens.
**Refers to continuous manufacturing improvement processes undertaken by CooperVision to reduce its Scope 1 and 2 carbon emissions.
††Carbon footprint is limited to Scope 1 and 2 emissions, defined as: Scope 1 emissions are direct emissions from owned or controlled sources. Scope 2 emissions are indirect emissions from the generation of purchased energy.
‡‡CooperVision's 2022 Environmental, Social, and Governance Report.
References:
1. CVI data on file, 2023.
2. CVI data on file, 2021. Rx coverage database n=101,973 aged 14 to 70 years.
3. CVI data on file, 2026.
4. CVI data on file, 2026. Industry reports and internal estimates based on Tyler's Quarterly, 06/2025 and competitor websites.
5. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. OVS 2019;96(8):556-567.
6. Chamberlain P, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. OVS 2022 Mar 1;99(3):204-212.
7. Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight 1 day 7 year findings. OVS 2025 In Press;98:E-abstract 210049.
8. Woods J et al. Ocular health of children wearing daily disposable contact lenses over a 6-year period. CLAE 2021 Aug;44(4):101391.
9. Sulley A et al. Experience and subjective responses for children switched from single vision to dual focus myopia control daily disposable contact lenses. BCLA paper presentation 2021.
10. Jakobsen, Møller. Control of myopia using orthokeratology lenses in Scandinavian children aged 6 to 12 years. Eighteen-month data from the Danish Randomized Study: Clinical study Of Near-sightedness; Treatment with Orthokeratology Lenses (CONTROL study). Acta Ophthalmol. 2022 Mar;100(2):175-182.
11. Lu et al. Efficacy of Trial Fitting and Software Fitting for Orthokeratology Lens: One-Year Follow-Up Study. Eye Contact Lens. 2018 Sep;44(5):339-343.
12. Rappon et al. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomized controlled, efficacy and safety study (CYPRESS). British Journal of Ophthalmology. Published Online First: 01 September 2022.
13. Laughton et al. Safety and Efficacy of a Novel Spectacle Lens for Myopia Control Over Three Years. 2022 American Academy of Optometry annual meeting.
20291 09/26